SCHEMBL7796498

SCHEMBL7796498

NS(=O)(=O)c1ccc(-n2nc(CO)cc2-c2ccc(O)cc2)cc1

nearest known ligand 0.80

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 15/20 0.80
CA1 P00915 14/20 0.80
CA2 P00918 14/20 0.80
PTGS2 P35354 6/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6531306 0.89 CA9 (1.00) CA9CA1CA2PTGS2
SCHEMBL213633 0.89 PTGS2 (1.00) CA9CA1CA2PTGS2
SCHEMBL3866594 0.89 CA9 (1.00) CA9CA1CA2PTGS2
SCHEMBL17369625 0.89 CA9 (0.78) CA9CA1CA2PTGS2
SCHEMBL6344401 0.89 CA9 (1.00) CA9CA1CA2PTGS2
SCHEMBL7799049 0.87 CA9 (0.75) CA9CA1CA2PTGS2
SCHEMBL6343859 0.86 CA1 (1.00) CA9CA1CA2PTGS2
SCHEMBL7796692 0.86 CA9 (0.70) CA9CA1CA2PTGS2
SCHEMBL6514587 0.84 CA9 (0.74) CA9CA1CA2PTGS2
SCHEMBL20042417 0.83 PTGS2 (0.67) CA9CA1CA2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010055565-A1 Method of detecting cyclooxygenase-2 G.D. SEARLE & CO. (US) 2001-12-27 US claimed
US-6045773-A Method of detecting cyclooxygenase-2 G.D. SEARLE & CO. (US) 2000-04-04 US claimed
EP-0859642-A2 METHOD OF DETECTING CYCLOOXYGENASE-2 G.D. SEARLE & CO. (US) 1998-08-26 EP claimed
WO-1997014679-A2 METHOD OF DETECTING CYCLOOXYGENASE-2 G.D. SEARLE & CO. (US) 1997-04-24 WO claimed
US-20010055565-A1 Method of detecting cyclooxygenase-2 G.D. SEARLE & CO. (US) 2001-12-27 US disclosed
US-6045773-A Method of detecting cyclooxygenase-2 G.D. SEARLE & CO. (US) 2000-04-04 US disclosed
EP-0859642-A2 METHOD OF DETECTING CYCLOOXYGENASE-2 G.D. SEARLE & CO. (US) 1998-08-26 EP disclosed
WO-1997014679-A2 METHOD OF DETECTING CYCLOOXYGENASE-2 G.D. SEARLE & CO. (US) 1997-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010055565-A1 Method of detecting cyclooxygenase-2 PTGS2, PTGES2, PTGER2 CA9 1122/4885CA1 906/4885CA2 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.